Two-Day Symposium for Molecular Biologists involved in Molecular Pathology Diagnostics and Research
The Two-Day Symposium for Molecular Biologists involved in Molecular Pathology Diagnostics and Research will again broaden the spectrum of the European Congress of Pathology. The symposium will take place on Monday, 10 September 2018 and Tuesday, 11 September 2018.
Our increasing knowledge of the molecular basis of disease opens the doors to new therapy options for cancer patients. The use of molecular data nowadays directly impacts patient treatment. The major goals for scientists working together with pathologists and clinicians in the field are to provide high-quality molecular diagnostics but at the same time to translate basic research discoveries into clinical practice.
In this workshop current advances but also challenges and problem-solving approaches in the field of molecular pathology will be addressed and discussed. The symposium will focus primarily on the interests of molecular biologists working in pathology molecular diagnostics and research.
Monday, 10 September 2018
08:30 - 15:45 MB-01 | Immunotherapy biomarkers
Chairs: Marjolijn Ligtenberg, The Netherlands Sabine Merkelbach-Bruse, Germany
001 08:30 - 09:30 Update in immuno-oncology - a clinician's view David Heigener, Germany
09:30 - 10:30 Coffee Break
002 10:30 - 11:00 Multiparametric biomarkers for immunotherapy: the lung cancer paradigm Fernando Lopez-Rios, Spain
003 11:00 - 11:30 Evaluation and harmonisation of biomarkers for checkpoint therapy in France Etienne Rouleau, France
004 11:30 - 12:00 The German TMB consortium: comparing and harmonising mutational load assays Albrecht Stenzinger, Germany